{'fraction_non_alphanumeric': 0.02176541717049577, 'fraction_numerical': 0.016928657799274487, 'mean_word_length': 5.225563909774436, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Sclerocystic ovaries and cancer of the uterine body].

As a result of investigation and treatment of 5000 patients with disorders in menstrual function and endocrinous sterility sclerocystic ovaries were diagnosed in 1.8-2% (90 patients). In 6 of them ovarian changes were associated with cancer of the uterine body. In uterine body cancer and sclerocystic ovaries opsomenorrhea and menorrhagia, obesity were of great persistance, the duration of the disease being 12-20 years. Based on the conducted investigations it is considered rational to perform a wedge resection as early as possible, but not following many years of unsuccessful hormone therapy, and to study histologically endometrial curettage specimens. In recurrence of the disease and enlargement even of one ovary a repeat wedge ovariectomy should be performed.